In a significant move, the Union government on Tuesday allowed emergency use of foreign Covid-19 vaccines through a fast-track route, striking off the need for a prior local trial. In line with the recommendations of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), vaccines which have been developed and are being manufactured in foreign countries, with approval from health regulators in the US, UK, European Union and Japan, would now be permitted for emergency use in India. Those in the World Health Organisation (WHO) emergency use list will also be allowed. Instead of prior local clinical trials, companies must do parallel clinical trials after vaccine enters the India market. Also, the first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before an expansion of the immunization programme, the health ministry said in a statement.
Expert panel recommends approval to Russia s Sputnik V Covid-19 vaccine business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
Covid-19: Nepal asks India to facilitate supply of vaccine medicaldialogues.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicaldialogues.in Daily Mail and Mail on Sunday newspapers.
The government is in contact with the Serum Institute of India and other pharmaceutical companies to look at ways that they can ramp up production of anti-Covid vaccines at a time when several states have said that they are running out of stocks